Bone scintigraphy with<sup>99m</sup>technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis
Andor W.J.M. Glaudemans(Boston University), Bouke P. C. Hazenberg(University Medical Center Groningen), Walter Noordzij, Ronald W. J. van Rheenen(Society of Nuclear Medicine and Molecular Imaging), Rudi Dierckx(University Medical Center Groningen), Maarten P. van den Berg(Regions Hospital), Riemer H. J. A. Slart(University Medical Center Groningen), Michel Koole(KU Leuven), Hans Blokzijl(University Medical Center Groningen)
Cited by 147
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
|Journal of the American College of Cardiology|2012|519